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Current progress of skin tissue engineering: 
Seed cells, bioscaffolds, and construction 
strategies
Introduction
As the largest organ, skin covers the entire exterior of  the 
body and takes over about 8% of  the total body mass. Due 
to its direct exposure to potentially harmful microbial, 
thermal, mechanical, and chemical damages, the loss of  
skin can occur for many reasons, including disorders, acute 
trauma, chronic wounds, or even surgical interventions.[1] 
Tissue-engineered skin (TES) substitutes represent a logical 
therapeutic option for the treatment of  acute and chronic 
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skin wounds. Since the successful isolation and cultivation 
of  human epidermal keratinocytes in 1975,[2] TES has 
developed from epidermal substitutes to full-thickness skin 
containing different seed cells [Figure 1]. According to 
their anatomical structures, skin substitute products could 
be classified into cellular epithelial autografts, engineered 
dermal substitutes, and engineered dermo-epidermal 
composite substitutes.[3] All these products have become 
a prospective measure for clinical treatment of  large full-
thickness skin defects.
Recently, highly innovative progress in the development and 
clinical use of  highly sophisticated TES in order to increase 
their medical safety, durability, elasticity, biocompatibility, 
and clinical efficacy has been reported. Here, we give a brief  
introduction to some representative progress in feasible 
seed cells and supportive biomaterials, as well as their 
applications in varied TES substitutes in developing our 
understanding of  skin tissue engineering.
A B S T R A C T
The development of cell biology, molecular biology, and material science, has been propelling biomimic tissue-engineered skins to 
become more sophisticated in scientifi city and more simplifi ed in practicality. In order to improve the safety, durability, elasticity, 
biocompatibility, and clinical eﬃ  cacy of tissue-engineered skin, several powerful seed cells have already found their application in 
wound repair, and a variety of bioactive scaﬀ olds have been discovered to infl uence cell fate in epidermogenesis. These exuberant 
interests provide insights into advanced construction strategies for complex skin mimics. Based on these exciting developments, a 
complete full-thickness tissue-engineered skin is likely to be generated.
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Figure 1: A schematic diagram of a desirable full-thickness TES. (a) 
The relatively thin keratinized epidermal layer provides protective 
function that prevents infection and fl uid loss. (b) A much thicker 
dermal layer underlies the upper layer and consists of abundant 
mesenchymal cells and ECM proteins, forming the basal body of 
TES. (c) To increase the survival of TES, a well-vascularized layer 
containing nerve receptors should be integrated under the dermal 
capillary network. (d) Skin appendages including hair follicles and 
sweat glands embedded in the dermal layer are also indispensable 
parts of full-thickness TES that best mimic the function as well as 
appearance of normal skin.
Seed cells for skin tissue engineering
Skin-derived seed cells
Keratinocytes
Up to 1980s, the development of in vitro expansion technique 
unveils the unlimited proliferation capacity of  keratinocytes 
that, they are capable of being passaged for many hundreds of  
generations without undergoing senescence.[4] Such exciting 
characteristics make keratinocyte an ideal alternative 
treatment for large burns, instead of  skin grafting. Since 
then, numerous clinical trials have demonstrated the 
efficacious application of  cultured keratinocytes in 
wound healing.[5,6] As the first step of  treatment with 
skin substitutes, single cell suspension and multilayered 
‘‘keratinocyte sheet” were explored.[7,8] However, due to 
lack of  dermal structures, simple keratinocyte coverage is 
fragile and the take rate varies depending on the condition 
of  the defected area. These major disadvantages make 
keratinocytes not optimal for the coverage of  full-thickness 
defects [Table 1]. To further facilitate cell survival and 
growth, several bioscaffolds were comprised into the 
keratinocytes containing TES, such as collagen,[9] gelatin,[10] 
fibrin,[11] chitosan,[12] and various synthetic materials.[13-15] 
Moreover, in order to overcome some major drawbacks like 
scar formation and contracture, more dermal lineage seed 
cells need to be utilized to support the tissue-engineered 
constructs.
Dermal fibroblasts
As the major cell type present in the dermis, fibroblast 
plays an important role in the wound healing process 
by producing extracellular matrix (ECM) proteins 
and cytokines. It has been shown that the presence of  
fibroblasts in three-dimensional (3D) constructs could 
significantly increase the survival[16] and proliferation[17] 
rate of  keratinocytes. In a bilayered model, the underlying 
fibroblast promoted the keratinocyte layer into basal, granular, 
and cornified layers, in addition to promoting keratinocyte 
proliferation.[18] In addition, the synthesis and deposition 
collagen and other ECM components form the basis 
of  the granulation tissue, which is a critical process 
in wound healing. Besides, in response to site-specific 
microenvironment, fibroblasts from undamaged tissue are 
able to migrate to the wound and transdifferentiate into 
myofibroblasts that take on a contractile phenotype.[19] Such 
characteristics make the fibroblasts a popular candidate 
for skin substitutes, especially those containing dermal 
equivalents.













Keratinocytes E • • •* • [4-6]
Dermal fibroblasts D • • • [17, 19]
Epidermal stem cells E/D • • • • [20, 22, 25, 26]
Melanocytes E • • • [30]
Non-cutaneous cells
Embryonic stem cells E/D • •* • • [32-34, 36]
Inducible pluripotent stem cells E/D • • •* • • • • [32, 40-42]
Mesenchymal stem cells E/D • • • [47, 48, 50, 51]
Endothelial cells D • • • [58, 59]
Amniotic cells E/D • [63, 64]
E, epidermis; D, dermis; E/D, epidermis or dermis; ●, reported character; *, feeder cell needed
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Epidermal stem cells
Epidermal stem cells are a population of  adult somatic 
stem cells specifically located in the basal cell layer of  the 
epidermis. In addition to their low tendency to divide, 
their extensive and sustained self-renewal capacity plays 
an essential role in the lifelong epidermogenesis and 
wound repair of  the skin.[20,21] Studies have shown that 
epidermal stem cells can be inducted into epidermis and 
its appendages such as sweat gland, hair follicle, and 
sebaceous follicle under certain microenvironments.[22-24] 
However, one major technical challenge that hampers 
the wide application of  epidermal stem cells in skin 
tissue engineering is lack of  specific surface antigens 
for their isolation or enrichment. To overcome this 
problem, several methods have been used to identify and 
differentiate them from other types of  cells residing in 
the epidermis.[4,25,26] Since most epidermal stem cells were 
discovered from the “bulge” region of  the hair follicle,[22,27] 
it is logically predicable to find out that epidermal stem 
cells have the ability to rebuild skin appendages such as 
hair follicle and sweat gland when applied in skin tissue 
engineering.[28] Although the regulation of  epidermal stem 
cell differentiation is not clearly understood, these researches 
provide hope that functional skin substitutes equipped with 
appendages can be generated for transplantation in, for 
example, cases of  extensive burns.
Melanocytes
Melanocytes are found in the lower layer of  the epidermis 
and provide pigments to determine skin color. Theoretically, 
they are ideal seed cells to resolve the lacking of  natural 
skin pigmentation which is one major esthetic concern 
in the current cultured skin grafts. In vitro reconstruction 
of  keratinocytes combined with melanocytes on de-
epidermized human dermis could result in a colored 
equivalent to natural epidermis.[29] Our previous work 
also revealed the feasibility of  melanocytes in skin tissue 
engineering. After transplantation of  constructed skin 
containing keratinocytes, melanocytes, and dermal 
fibroblasts, athymic mice generated black skins within 6 
weeks.[30] Interestingly, in vivo research conducted by Hachiya 
et al. found that melanocytes are capable to spontaneously 
localize to the basal layer from a mixed cell slurry containing 
keratinocytes, fibroblasts, and melanocytes. In addition, 
the synthesized melanosome could be correctly transferred 
to keratinocytes after ultraviolet irradiation.[31] However, 
functional pigmentation is only the beginning, advanced 
method on controlling the production of  appropriate 
amount of  melanin deserves further investigation, in order 




Embryonic stem cells (ESCs) are referred as pluripotent 
cells derived from inner cell mass of  a blastocyst. With 
non-senescing self-renewal and differentiation capability 
into three germ layers, ESCs might offer a way to meet 
the challenge of  biomimetic complex skin constructs. To 
initiate epidermal differentiation of  ESCs, several protocols 
have been developed.[32-34] Besides, the transcriptional 
similarity of  ESC-derived keratinocyte lineage and primary 
foreskin keratinocytes has been proved by microarray 
analysis, suggesting these cell types respond to specific 
microenvironment in a similar manner.[35] When grown 
in specific media and substrate conditions, ectodermal 
and mesenchymal cells derived from ESCs are capable 
of  generating 3D epithelial tissue.[36] In a preclinical 
study, ESC-derived keratinocytes formed a pluristratified 
epidermis when seeded on an artificial matrix and finally 
regenerated a fully functional mature skin-like structure 
after in vivo implantation.[37] These studies provide a 
theoretical basis for the use of  ESCs as seed cells for TES. 
However, embryonic stem cell research is handicapped by 
moral and ethical restraints, and the source of  ESCs is thus 
problematic.[38]
Inducible pluripotent stem cells
In 2006, inducible pluripotent stem cells (iPSCs) were first 
discovered by Yamanaka and colleagues, who received The 
Nobel Prize in Physiology or Medicine in 2012 (jointly 
with John B. Gurdon) for the finding that mouse fibroblasts 
could acquire properties similar to those of  ESCs after 
“reprogramming.”[39,40] Since this milestone, iPSCs have 
become a promising new source of  stem cells for skin tissue 
engineering without any moral and ethical controversies. 
Recent publications show that procedures differentiating 
mouse iPSCs into epidermal keratinocytes are similar to 
keratinocyte differentiation of  ESCs.[32,41-43] By using the 
iPSCs-derived keratinocyte lineage cells, Bilousova et al., 
have successfully regenerated epidermis, hair follicles, and 
sebaceous glands in the skin of  athymic nude mouse.[41] 
Though the exciting development has been achieved, utility 
of  iPSCs for medical applications is still pending because 
of  the possibility that the transgene technology may cause 
carcinogenesis and tumor formation.[44] As novel technologies 
relating to iPSCs are rapidly being developed,[45] the 
therapeutic applicability of  iPSCs in skin tissue engineering 
and regenerative medicine will eventually be a reality.[46]
Mesenchymal stem cells
Mesenchymal stem cells are identified from functional 
tissues after birth (such as bone marrow, adipose, blood, 
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and umbilical cord) and differ from ESCs in that they are 
more restricted in their proliferation and differentiation 
potential and cannot spontaneously give rise to complex 
tissues in vitro.[47] Among these, bone marrow mesenchymal 
stem cells (BMSCs) and adipose-derived stem cells (ADSCs) 
are perhaps the most promising candidates for skin 
regeneration.[48] The potential of  such MSCs to differentiate 
into dermal cells has been described.[49,50] However, unlike 
many encouraging publications in the past decade that the 
differentiation of  BMSCs across germinal boundaries is 
crucial for regeneration of  injured tissues, recent reports 
suggest that the growth factors secreted by BMSCs are 
more important in stimulating proliferation and maturation 
of  endogenous stem cell-like progenitors and decreasing 
inflammatory reactions.[51,52] Except for the trophic and 
immunomodulatory functions, BMSCs demonstrated 
abundant ECM remodeling, matrix contraction, 
and migration capability when cultured on dermal 
equivalents.[53,54] Evidences as our work showed that 
MSCs containing skin equivalent exhibited better healing 
and keratinization, less wound contraction, and more 
vascularization in a porcine deep partial-thickness burn 
wound model.[55] One study of  a murine model of  full-
thickness defect treated with a biograft composed of  
ADSCs showed increased rate of  re-epithelialization and 
vascularization.[56] Our preliminary work researched the 
vascularization capacities of  two different scaffolds seeded 
with ADSCs – decellularized small intestinal submucosa 
(SIS) and acellular dermal matrix (ADM) – and found 
that both the ADSCs combining biomaterials revealed 
enhanced angiogenesis and wound healing rate compared 
with the non-seeded scaffolds.[57] All these findings strongly 
demonstrate that adult BMSCs/ADSCs can contribute to 
the healing of  injured skin and might provide a cell resource 
for building TES.
Endothelial cells
Delivering cells of  endothelial origin remains the most 
systematic approach to enhance neovascularization in 
TES equivalents, as these cells are destined to directly 
contribute to vessel formation.[58,59] Moreover, interactions 
between different seed cells with endothelial cells (ECs) may 
contribute to vascularization in TES through angiogenesis 
and/or vasculogenesis. By co-culturing dermal fibroblasts 
and ECs in collagen sponge in vitro, a complex vascular 
network with branching structures was formed.[60] In 
subsequent research using skin fibroblasts and ECs, Kunz-
Schughart et al. verified that fibroblast could interact and 
support the migration, viability, and network formation of  
ECs.[61] Our result demonstrates an obvious implication 
of  this work that a scaffold-free bilayered TES containing 
dermal fibroblasts together with dermal microvascular 
ECs could form capillary-like structures after 20 days of  
culture. Also, this vascularization process is associated 
with interactions among keratinocytes, fibroblasts, and 
ECs.[62] To further facilitate the clinical use of  ECs, however, 
researches on overcoming their disadvantages like limited 
in vitro expansion capacity and potent immunogenicity are 
desiderated.
Amniotic cells
Due to the easy-to-gain and layered pattern, human 
amniotic membrane (AM) has a long history in skin wound 
healing.[63] Except for its mechanical support and protection, 
the epithelial regeneration and immunosuppressive 
potential of  cellular components (namely, amniotic 
epithelial cells and amniotic mesenchymal cells) in AM 
have received much attention recently.[64] For the first time, 
our previous research has shown the feasibility of  both 
amniotic epithelial cells and amniotic mesenchymal cells 
in reconstruction of  bilayered skin equivalent and thereafter 
skin regeneration.[65] Besides, recent work indicates that 
amniotic fluid-derived cells could act as a substitute seed 
cell for fibroblast in tissue-engineered dermo-epidermal skin 
analog.[66] Taken together, these findings suggest amnion 
might be a new source for obtaining the seed cells to develop 
new skin products for clinical application.
Bioscaffolds in skin tissue engineering
The selection and optimization of  a biomaterial scaffold 
plays a pivotal role in skin tissue engineering. Except 
for their mechanically supportive function, efficacious 
biocompatible scaffolds should assist the successful 
engraftment of  TES, as they expediently accrete 
wound and promote granulation tissue formation, 
fibroblast-driven remodeling, angiogenesis,  and 
re-epithelialization.[67] However, novel concepts of  skin 
tissue engineering extend new and specific requirements 
for biomimetic scaffolds,[68] based on which many 
interesting natural and synthetic polymers have been 
used in constructing artificial skin.
Natural polymers
Collagenous biomaterials
As a major ECM protein of  the dermal layer of  the 
skin, collagen is the most widely studied and clinically 
utilized natural scaffold available for TES substitutes. The 
advantages include good biocompatibility, proper porous 
structure, as well as low immunogenicity.[55,67,69] However, 
the poor mechanical strength and rapid biodegradation rate 
of  natural collagen scaffolds limiting the graft instability 
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are the critical disadvantages that hamper its applications. 
Therefore, to control the degradation, numerous 
works have focused on the mechanical properties of  
collagen, such as chemical and biophysical cross-linking 
techniques[70,71] or a structural modification method like 
dense film.[72] For example, addition of  matrix protein 
tropoelastin to type I collagen enhanced the proliferation 
and migration rates of  dermal fibroblasts in vitro.[73] 
Cross-linking collagen with chitosan after electrospinning 
resulted in a good potential for keratinocyte migration 
and wound re-epithelialization.[15] Addition of  fibroblast 
growth factor 2 (FGF-2) or vascular endothelial growth 
factor (VEGF) to heparin cross-linked collagen scaffold 
increased its angiogenic potential.[74] Although effective 
modification and improvement have been made, other 
discouraging problems in collagen-based polymers for 
skin tissue engineering still exist, including the high 
cost of  purification process, potential viral and prior 
contamination,[75] and variability in the physicochemical 
properties depending on source and processing.[76]
Noncollagenous biomaterials
Except for collagen, some other natural polymers have been 
investigated as scaffolds for skin tissue engineering, including 
gelatin, hyaluronic acid, fibrin, laminin, and elastin. Under 
various process conditions, these proteinic polymers could 
form different phases such as suspensions,[77] gels,[78,79] 
sponges,[80] films, or sheets.[81] Though these naturally 
derived molecules have been considered advantageous 
in their cell interaction and signaling contributions, the 
mechanical properties of  these materials are often poor 
in comparison to the properties of  synthetic materials.[82] 
Therefore, the noncollagenous biomaterials, like collagen 
itself, are often organized into synthetic matrices or to retain 
their stability and mimic the natural ECM.
Acellular matrices
ADM, which is derived from full-thickness skin by 
removing cells and cellular components rather than native 
dermal structure and extracellular proteins, has been 
successfully used both in pre-clinical animal studies and 
in human clinical applications.[83,84] Retaining structural 
and functional proteins that constitute the ECM, including 
collagen, fibronectin, laminin, and vimentin,[85] ADM 
provides an intrinsic microenvironment for cell adhesion 
and proliferation. Previous studies demonstrate that 
endogenous growth factors such as VEGF, FGF-2, and 
transforming growth factor 1 remain on ADM and are 
released into the surrounding tissue to accelerate processes 
such as angiogenesis, cell recruitment, cell division, and 
even potential antimicrobial activity.[86,87] Such biological 
benefits have led to the application of  ADM-based skin 
substitutes in burn coverage for decades.[88,89] Besides its 
natural structures, our results show that even micronized 
ADM still facilitates cell adhesion and growth in vitro as 
well as forms a thick layered tissue when transplanted into 
subcutaneous muscle.[90]
Synthesized materials
Compared to biological biomaterials, artificially 
synthesized polymers such as polyurethane (PU), 
polypropylene (PP),[91] polyglycolic acid (PGA), polylactic 
acid (PLA), and their copolymer poly (lactic-co-glycolic 
acid) (PLGA) display controllable mechanical properties 
and diverse plasticity.[92] It has been proved that PLGA-
knitted matrix exhibits sufficient internal space for tissue 
ingrowth, in addition to its skeletal role in enhancing natural 
biopolymers like collagen.[93,94] Other polymeric biomaterials 
like polyvinyl alcohol (PVA) are capable of  increasing 
structural stability and tensile strength, and improving 
initial cell proliferation when blended with collagen.[95] 
Unfavorable cell adhesion materials like poly (dl-lactide) 
(PDLLA) could interact and integrate well with dermal 
fibroblasts after addition of  30% poly (ethylene glycol) 
(PEG) before electrospinning.[96] Polyhydroxybutyrate 
(PHB) combines with organic-soluble chitosan and also 
reveals beneficial effect on promoting cell attachment 
and proliferation.[97] The progress in controlling scaffold 
property is exciting, but most of  the current studies just 
demonstrate novel materials or methods without making 
comparison with any other available TES constructs. 
Predictably, but disappointingly, these works accumulate 
limited knowledge about the materials and their properties 
that are most suitable for TES.
To differentiate natural and artificial biomaterials from 
one another in only one specific aspect, several arrays 
screening of  biomaterial have been developed.[98-100] 
These efforts provide in vitro pre-screening data for the 
selection of  appropriate set of  matrix molecules for skin 
tissue engineering. However, due to the complexity of 
in vivo microenvironment, more works such as testing 
different types of  cells and additional modifications 
need to be extended in order to increase the possibility to 
successfully predict optimal biomaterials for skin tissue 
engineering.
Current strategies for TES construction
With various approaches presently being developed 
in different laboratories and companies, a number of  
artificial skin equivalents are commercially available and 
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many others are under development.[101] According to the 
complexity of  their anatomical structures, the construction 
of  TES could be classified from single-layered ones to ones 
with more than two layers.
Single-layered substitutes
Epidermal substitutes
Based on the achievements made in in vitro cultivation and 
expansion of  human keratinocytes, multiple autologous 
epidermal substitutes have been developed for re-
epithelialization either by cell suspension (e.g. CellSpray[102]), 
subconfluent layer (e.g. Myskin[103]) or by sheet (e.g. 
Epicel,[104] EpiDex,[105] and EPIBASE[106]). The application 
of  epidermal substitutes directly mitigates the deficiency 
of  skin biopsy. However, the clinical integration of  such 
cultured epithelial autografts is unpredictable and mostly 
relies on the condition of  the wound bed, rather than the 
terminally differentiated keratinocytes.[1] Besides, the poor 
mechanical property and development of  contractures due 
to the lack of  dermis are also problematic to the epidermal 
substitutes.[107] This resulted in further requirements 
concerning the development of  dermal substitutes. 
Dermal substitutes
The mechanical stability and elasticity provided by dermal 
layer could prevent wound contraction and scar hyperplasia. 
In case of  full-thickness burns, both dermal and epidermal 
equivalents must be applied consecutively, in order to generate 
suitable nutritional and immunological environment before 
the application of  epidermal layer. A large variety of  
acellularized dermal substitutes mainly produced from 
allogeneic, xenogeneic dermal matrices (e.g. AlloDerm,[108] 
GraftJacket,[109] and Matriderm[110]) or synthetic materials 
(e.g. Integra,[111] Biobrane,[112] and Hyalomatrix PA[113]) 
could stimulate the ingrowth of  autogeneic ECs and 
fibroblasts that help defected areas form dermal structure 
after transplantation, while some of  the bioactive dermal 
substitutes consisting of  human neonatal fibroblasts (e.g. 
Dermagraft[114] and TransCyte[115]) spontaneously show 
benefits in vascularization, epidermalization, as well as 
ECM formation. 
Double-layered substitutes
Double-layered skin substitutes combine both epidermal 
and dermal layers to histologically mimic the structure of  
normal skin. Without economic consideration, currently 
the epidermal/dermal composite TES (e.g. Apligraf[116]) 
represents the best treatment for skin repair, when compared 
with single-layered products. In skin tissue engineering, 
the interaction between parenchyma and stroma appears 
to be instructive in programming tissue structure and 
function during epidermogenesis.[117] It is widely accepted 
that the inductive effects of  fibroblasts on epithelial 
morphogenesis are mediated by cell-cell interactions 
and ECM secretion.[118,119] Due to the interplays between 
multiple seed cell types, epidermal/dermal substitutes show 
enhanced wound closure and keratinization capability. 
A full-thickness living skin analogue (Activskin[120]) 
developed by our team has been used to treat refractory 
ulcers successfully in clinical applications. The treatment 
of  refractory ulcers has drawn greater attention in recent 
decades owing to the increase in life expectancy in the 
industrialized world and the associated increase in the 
prevalence of  comorbid conditions such as diabetes and 
vascular disease.[121]
More complicated substitutes
In addition to the clinically available TES, great efforts have 
been made exploring optimized 3D constructs to repair 
skin tissue. Recent advances in skin biology have stressed 
the importance of  cell-cell interactions during epidermal 
morphogenesis. In particular, progress in the field of  
skin tissue engineering has contributed tremendously to 
our knowledge about in vitro epidermal morphogenesis, 
resulting in the reconstruction of  highly sophisticated and 
innovative 3D skin equivalents that mimic human skin in 
terms of  tissue architecture and function, including hair 
follicle,[122] capillary network,[59,62] sensory innervation,[123] 
adipose tissue,[124] and pigment production.[30,125] When 
grown in the environment that mimics the anatomical 
position of  skin, these bioengineered skins present 
definite differences in epidermal regeneration according 
to the types of  seed cells used in the dermal substitutes. 
An exhilarating advancement is the elucidation of  the 
crucial role of  MSCs in skin regeneration. Apart from the 
morphogenesis potential, recent experimental evidence 
also demonstrates that BMSCs combined with epidermal 
stem cells could accelerate wound re-epithelialization 
and have better therapeutic potential in activating blood 
vessel and hair follicle formation than epidermal stem cells 
alone.[126] Like BMSCs, ADSCs are capable of differentiating 
into various skin cells which subsequently contribute to 
the wound healing.[127] The result obtained in our recent 
study in a bilayered TES system shows that a mixture of  
dermal fibroblasts and ADSCs in a ratio of  1:1 is superior 
to fibroblasts or ADSCs alone in promoting keratinocyte 
proliferation and differentiation.[128] With the steps into 
wound healing mechanisms, proper combinations of  cells 
and their interplays in initiating healing may be a way out 
for permanent TES construction.
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Challenges and perspectives
Currently, most of the TES could only function as temporary 
substitutions in skin wound healing. Lack of immediate blood 
supply and activation of immune rejection are the two major 
problems preventing the permanent integration of allogeneic 
TES. Evidences have shown that most of  the cells contained 
in TES do not survive for 1 month after transplantation.[129] 
This temporary nature, whether the substitutes are degradable 
or have to be removed, makes TES predominantly serve as 
“coverings” instead of  a real organic regenerator. However, 
it is reasonable to believe that with the development of  skin 
biology, material science, and engineering technology, the 
TES will finally have an equivalent structural and functional 
therapeutic outcome as autogeneic skin transplantation does.
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